Analyst Ratings for [SNY] Sanofi ADS (Each repstg one-half of one ordinary share)

8/8/25	Upgrades	Neutral Overweight	X
SNY Sanofi JP Morgan
4/15/25	Initiated	Outperform	X
SNY Sanofi Exane BNP Paribas
$65
3/21/25	Initiated	Neutral	X
SNY Sanofi Goldman
$65
1/30/25	Upgrades	Sell Hold	X
SNY Sanofi Deutsche Bank
7/26/24	Reiterated	Buy	X
SNY Sanofi Argus
$55 $60
1/23/24	Initiated	Equal-Weight	X
SNY Sanofi Morgan Stanley
$55
1/16/24	Resumed	Buy	X
SNY Sanofi UBS
12/5/23	Downgrades	Overweight Neutral	X
SNY Sanofi JP Morgan
10/30/23	Downgrades	Buy Hold	X
SNY Sanofi Stifel
9/6/23	Upgrades	Hold Buy	X
SNY Sanofi Berenberg
7/14/23	Initiated	Buy	X
SNY Sanofi HSBC Securities
4/28/23	Downgrades	Hold Sell	X
SNY Sanofi Deutsche Bank
3/27/23	Upgrades	Eq Weight Overweight	X
SNY Sanofi Barclays
12/13/22	Resumed	Overweight	X
SNY Sanofi Morgan Stanley
8/12/22	Upgrades	Sell Hold	X
SNY Sanofi Deutsche Bank
8/9/22	Downgrades	Buy Neutral	X
SNY Sanofi UBS
5/23/22	Initiated	Outperform	X
SNY Sanofi SVB Leerink
1/15/21	Initiated	Sell	X
SNY Sanofi Deutsche Bank
8/14/19	Upgrades	Neutral Buy	X
SNY Sanofi UBS
12/11/18	Upgrades	Hold Buy	X
SNY Sanofi Jefferies
11/1/18	Upgrades	Underweight Eq Weight	X
SNY Sanofi Barclays
10/9/18	Initiated	Neutral	X
SNY Sanofi Guggenheim
9/10/18	Upgrades	Neutral Buy	X
SNY Sanofi BofA/Merrill
8/10/18	Upgrades	Neutral Buy	X
SNY Sanofi Citigroup
3/23/18	Upgrades	Hold Buy	X
SNY Sanofi Liberum

SNY Sanofi ADS (Each repstg one-half of one ordinary share)

Quotes: Barrons • SeekingAlpha • NASDAQ • Bloomberg • WSJ

Sanofi is a healthcare company, focused on patient needs and engaged in the research, development, manufacture and marketing of therapeutic solutions. The Company's segments are Pharmaceuticals, Human Vaccines (Vaccines), and Other. The Pharmaceuticals segment comprises the commercial operations of various franchises, including Speciality Care (Rare Diseases, Multiple Sclerosis, and Oncology), Diabetes and Cardiovascular, Established Prescription Products, Consumer Healthcare and Generics, and research and development, production and marketing activities for all of the Company's pharmaceuticals operations. The Vaccines segment is dedicated to vaccines and includes the commercial operations of the Company's vaccines division Sanofi Pasteur and dedicated research and development, production and marketing activities for the Company's vaccines operations. Its Rare Diseases products include Cerezyme, Cerdelga, Myozyme and Lumizyme, Fabrazyme, and Aldurazyme.